New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Immune system dysfunction may occur early in Alzheimer's disease

Immune system dysfunction may occur early in Alzheimer's disease

by CU Anschutz Medical CampusPET scan of a human brain with Alzheimer's disease. Credit: public domainAn association between inflammation biomarkers in both blood plasma and cerebrospinal flu
Neurology April 16,2024
Immune system dysfunction may occur early in Alzheimer's disease

Immune system dysfunction may occur early in Alzheimer's disease

by CU Anschutz Medical CampusPET scan of a human brain with Alzheimer's disease. Credit: public domainAn association between inflammation biomarkers in both blood plasma and cerebrospinal flu
Neurology April 16,2024
Evaluation of tau phosphorylation-related targets for Alzheimer's treatment

Evaluation of tau phosphorylation-related targets for Alzheimer's treatment

by Institute for Systems Biology MoscowPET scan of a human brain with Alzheimer's disease. Credit: public domainInSysBio continues to investigate the mechanisms underlying Alzheimer's disease
Neurology April 16,2024
Evaluation of tau phosphorylation-related targets for Alzheimer's treatment

Evaluation of tau phosphorylation-related targets for Alzheimer's treatment

by Institute for Systems Biology MoscowPET scan of a human brain with Alzheimer's disease. Credit: public domainInSysBio continues to investigate the mechanisms underlying Alzheimer's disease
Neurology April 16,2024
New discovery for how the brain 'tangles' in Alzheimer's disease

New discovery for how the brain 'tangles' in Alzheimer's disease

by University of QueenslandCredit: Dr. Juan Polanco et. al., The University of Queensland.University of Queensland researchers have discovered a new 'seeding' process in brain cells that
Neurology April 16,2024
New discovery for how the brain 'tangles' in Alzheimer's disease

New discovery for how the brain 'tangles' in Alzheimer's disease

by University of QueenslandCredit: Dr. Juan Polanco et. al., The University of Queensland.University of Queensland researchers have discovered a new 'seeding' process in brain cells that
Neurology April 16,2024
Drug target for Alzheimer's disease has dual action

Drug target for Alzheimer's disease has dual action

by Queensland Brain InstituteCredit: Queensland Brain InstituteResearchers have discovered a potential drug target for Alzheimer's disease—an enzyme which has effects on both the immune and nervou
Neurology April 16,2024
Drug target for Alzheimer's disease has dual action

Drug target for Alzheimer's disease has dual action

by Queensland Brain InstituteCredit: Queensland Brain InstituteResearchers have discovered a potential drug target for Alzheimer's disease—an enzyme which has effects on both the immune and nervou
Neurology April 16,2024
Alzheimer's researchers study drug efficacy in early stages of disease

Alzheimer's researchers study drug efficacy in early stages of disease

by Indiana University School of MedicineCredit: Pixabay/CC0 Public DomainMost drugs developed to treat Alzheimer's disease have for years been ineffective in clinical trials. Researchers from
Neurology April 16,2024
Alzheimer's researchers study drug efficacy in early stages of disease

Alzheimer's researchers study drug efficacy in early stages of disease

by Indiana University School of MedicineCredit: Pixabay/CC0 Public DomainMost drugs developed to treat Alzheimer's disease have for years been ineffective in clinical trials. Researchers from
Neurology April 16,2024
Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that
Neurology April 16,2024
Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that
Neurology April 16,2024
Alzheimer's researchers find clues to toxic forms of amyloid beta

Alzheimer's researchers find clues to toxic forms of amyloid beta

by University of California - Santa CruzDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Much of the research on Alzheimer's disease has focused
Neurology April 16,2024
Alzheimer's researchers find clues to toxic forms of amyloid beta

Alzheimer's researchers find clues to toxic forms of amyloid beta

by University of California - Santa CruzDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Much of the research on Alzheimer's disease has focused
Neurology April 16,2024
Alzheimer's genetics point to new research direction

Alzheimer's genetics point to new research direction

by Robyn Mills,University of AdelaideDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A University of Adelaide analysis of genetic mutations which c
Neurology April 16,2024
Alzheimer's genetics point to new research direction

Alzheimer's genetics point to new research direction

by Robyn Mills,University of AdelaideDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A University of Adelaide analysis of genetic mutations which c
Neurology April 16,2024
Leaders in Alzheimer's research herald the dawn of a new era in drug development based on biology of aging

Leaders in Alzheimer's research herald the dawn of a new era in drug development based on biology of aging

by Alzheimer's Drug Discovery FoundationCredit: Pixabay/CC0 Public DomainA combination of drugs will be needed to effectively treat or prevent Alzheimer's disease and leading experts say we ha
Neurology April 16,2024
Leaders in Alzheimer's research herald the dawn of a new era in drug development based on biology of aging

Leaders in Alzheimer's research herald the dawn of a new era in drug development based on biology of aging

by Alzheimer's Drug Discovery FoundationCredit: Pixabay/CC0 Public DomainA combination of drugs will be needed to effectively treat or prevent Alzheimer's disease and leading experts say we ha
Neurology April 16,2024
Alzheimer's disease raises the risk of severe COVID-19 and death from this viral disease

Alzheimer's disease raises the risk of severe COVID-19 and death from this viral disease

by Elton Alisson,FAPESPPatients with dementia and especially Alzheimer’s run a threefold risk of dying as a result of infection by SARS-CoV-2. The risk is six times greater if they are over 80,
Neurology April 16,2024
Alzheimer's disease raises the risk of severe COVID-19 and death from this viral disease

Alzheimer's disease raises the risk of severe COVID-19 and death from this viral disease

by Elton Alisson,FAPESPPatients with dementia and especially Alzheimer’s run a threefold risk of dying as a result of infection by SARS-CoV-2. The risk is six times greater if they are over 80,
Neurology April 16,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com